Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 55 results:
[ Συντάκτης(Desc)] Τίτλος Τύπος Έτος
Φίλτρα: Keyword is Thyroid Neoplasms  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Anagnostis, P., Florou P., Bosdou J. K., Grimbizis G. F., Iakovou I., Kolibianakis E. M., et al. (2021).  Decline in anti-Müllerian hormone concentrations following radioactive iodine treatment in women with differentiated thyroid cancer: A systematic review and meta-analysis.. Maturitas. 148, 40-45.
Anastasilakis, A. D., Ruggeri R-M., Polyzos S. A., Makras P., Molyva D., Campennì A., et al. (2013).  Coexistence of Graves' disease, papillary thyroid carcinoma and unilateral benign struma ovarii: case report and review of the literature.. Metabolism. 62(10), 1350-6.
Anastasilakis, A. D., Polyzos S. A., Makras P., Kampas L., Valeri R. Maria, Kyriakoulis D., et al. (2012).  Papillary thyroid microcarcinoma presenting as lymph node metastasis--a diagnostic challenge: case report and systematic review of literature.. Hormones (Athens). 11(4), 419-27.
C
Chatzikyriakidou, A., Chorti A., & Papavramidis T. (2019).  Association of Gene Polymorphism rs3027898 With Papillary Cancer Restricted to the Thyroid Gland: A Pilot Study.. In Vivo. 33(6), 2281-2285.
Chrisoulidou, A., Pazaitou-Panayiotou K., Georgiou E., Boudina M., Lytras K., Iakovou I., et al. (2010).  The hypothalamic-pituitary-adrenal axis in women with differentiated thyroid cancer.. Endocr Res. 35(3), 137-43.
Chrisoulidou, A., Pazaitou-Panayiotou K., Georgiou E., Boudina M., Kontogeorgos G., Iakovou I., et al. (2008).  Ectopic Cushing's syndrome due to CRH secreting liver metastasis in a patient with medullary thyroid carcinoma.. Hormones (Athens). 7(3), 259-62.
D
Doulias, T., Papaziogas B., Rosser J. H., & Koutelidakis I. (2013).  Thyroid neurofibroma in a female patient with neurofibromatosis type I: report of a case.. BMJ Case Rep. 2013,
F
Frangos, S., Iakovou I. P., Marlowe R. J., Eftychiou N., Patsali L., Vanezi A., et al. (2015).  Difficulties in deciding whether to ablate patients with putatively "low-intermediate-risk" differentiated thyroid carcinoma: do guidelines mainly apply in the centres that produce them? Results of a retrospective, two-centre quality assurance study.. Eur J Nucl Med Mol Imaging. 42(13), 2045-55.
Frangos, S., Iakovou I. P., Marlowe R. J., Eftychiou N., Patsali L., Vanezi A., et al. (2017).  Acknowledging gray areas: 2015 vs. 2009 American Thyroid Association differentiated thyroid cancer guidelines on ablating putatively low-intermediate-risk patients.. Eur J Nucl Med Mol Imaging. 44(2), 185-189.
G
Geropoulos, G., Psarras K., Papaioannou M., Giannis D., Meitanidou M., Kapriniotis K., et al. (2022).  Circulating microRNAs and Clinicopathological Findings of Papillary Thyroid Cancer: A Systematic Review.. In Vivo. 36(4), 1551-1569.
Giannoula, E., Iakovou I., & Verburg F. A. (2018).  Long term quality of life in differentiated thyroid cancer patients after thyroidectomy and high doses of I with or without suppressive treatment.. Hell J Nucl Med. 21(1), 69-73.
Giannoula, E., Gkantaifi A., & Iakovou I. (2016).  [Radiation treatment of head and neck carcinomas as a risk factor for thyroid carcinomas].. Hell J Nucl Med. 19(1), 65-74.
Giannoula, E., Iakovou I., & Chatzipavlidou V. (2015).  [Risk factors and the progression of thyroid malignancies].. Hell J Nucl Med. 18(3), 275-84.
H
Hatjiharissi, E., Diamantidis M. D., Papaioannou M., Dimou T., Chrisoulidou A., Patakiouta F., et al. (2013).  Long-term outcome of primary endocrine non-Hodgkin lymphomas: does the site make the difference?. QJM. 106(7), 623-30.
I
Iakovou, I., Chrisoulidou A., Balaris V., Balaris C., Doumas A., & Karatzas N. (2010).  Acute effects of recombinant human TSH on bone markers in differentiated thyroid cancer.. Hell J Nucl Med. 13(3), 208-12.
Iakovou, I., Goulis D. G., Tsinaslanidou Z., Giannoula E., Katsikaki G., & Konstantinidis I. (2016).  Effect of recombinant human thyroid-stimulating hormone or levothyroxine withdrawal on salivary gland dysfunction after radioactive iodine administration for thyroid remnant ablation.. Head Neck. 38 Suppl 1, E227-30.
K
Koukkou, E. G., Roupas N. D., & Markou K. B. (2017).  Effect of excess iodine intake on thyroid on human health.. Minerva Med. 108(2), 136-146.
L
Lypiridou, S., Papavramidis T., Michalopoulos A., Foka-Karagiannopoulou A., & Koletsa T. (2017).  Hürthle cell carcinoma in an unattached thyroid lobe: A diagnostic challenge.. Pathol Int. 67(10), 531-533.
M
Markantes, G. K., Karakioulaki M., Papanikolopoulou S., Theodoropoulou A., Markou K. B., Vagenakis A. G., et al. (2021).  Improving the prediction of persistent and recurrent differentiated thyroid cancer using the American Thyroid Association 2015 risk stratification system.. Hormones (Athens). 20(4), 761-768.
Markou, K. D., Goudakos J. K., Triaridis S., Televantou D., Hytiroglou P., & Nikolaou A. (2010).  Simultaneous metastatic papillary thyroid carcinoma and carcinoid of the small intestine in the cervical lymph node group.. Thyroid. 20(9), 1025-8.
Michalaki, M., Bountouris P., Roupas N. D., Theodoropoulou A., Agalianou N., Alexandrides T., et al. (2016).  Low-risk papillary thyroid carcinoma patients who underwent near-total thyroidectomy without prophylactic central compartment lymph node dissection and were ablated with low-dose 50mCi RAI had excellent 10-year prognosis.. Hormones (Athens). 15(4), 511-517.
Milias, S., Hytiroglou P., Kourtis D., & Papadimitriou C. S. (2004).  Granular cell tumour of the thyroid gland.. Histopathology. 44(2), 190-1.
Mitsiades, C. S., Kotoula V., Poulaki V., Sozopoulos E., Negri J., Charalambous E., et al. (2006).  Epidermal growth factor receptor as a therapeutic target in human thyroid carcinoma: mutational and functional analysis.. J Clin Endocrinol Metab. 91(9), 3662-6.
Mitsiades, C. S., McMillin D., Kotoula V., Poulaki V., McMullan C., Negri J., et al. (2006).  Antitumor effects of the proteasome inhibitor bortezomib in medullary and anaplastic thyroid carcinoma cells in vitro.. J Clin Endocrinol Metab. 91(10), 4013-21.
Mitsiades, N., Poulaki V., Mastorakos G., Tseleni-Balafouta S. T., Kotoula V., Koutras D. A., et al. (1999).  Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.. J Clin Endocrinol Metab. 84(8), 2924-32.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές